Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Carboplatin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 63 Lung Neoplasms 32 Squamous Cell Carcinoma of Head and Neck 18 Small Cell Lung Carcinoma 12 Ovarian Neoplasms 12 Breast Neoplasms 12 Triple Negative Breast Neoplasms 11 Fallopian Tube Neoplasms 11 Endometrial Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Neoplasms 10 Colorectal Neoplasms 9 Neoplasm Metastasis 8 Carcinoma 8 Head and Neck Neoplasms 7 Oropharyngeal Neoplasms 6 Laryngeal Neoplasms 6 Uterine Cervical Neoplasms 5 Mouth Neoplasms 5 Esophageal Neoplasms 5 Carcinoma, Transitional Cell 5 Carcinoma, Squamous Cell 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Thoracic Neoplasms 3 Salivary Gland Neoplasms 3

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡